
Search results - 7 results
Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
led to the use of sensitive HPV molecular tests for screening. This study examined the impact of the baseline HPV status on the future risk of cervical intraepithelial neoplasia grade 2 or worse (CIN2 ...
The EMPCAN study: protocol of a population-based cohort study on the evolution of the socio-economic position of workers with cancer
Publication Type: Peer reviewed scientific article Authors: Regine Kiasuwa; Victoria N Nyaga; Otter, Renée; De Brouwer, Christophe; Bouland, Catherine Source: Archives of Public Health, Volume 77, ...
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.
types and women unselected by HPV status. Expert commentary: All evaluated vaccines offered excellent protection against cervical intraepithelial neoplasia of grade 2 or 3 (CIN2 or CIN3) and ...
The use of the permanent sample (eps) to study the returnto- work after cancer. Challenges and opportunities for research
We observe during a five-year period the socio-professional status (inability, disability, unemployment or death) of 645 workers identified in the permanent sample (EPS), having had an oncological ...
Barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23-60 years.
knowledge, and screening compliance were obtained via self-administered questionnaire. RESULTS: Few respondents had low socioeconomic status. Mean total time and travel costs and direct non-medical cost per ...
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
antibodies against the vaccine HPV types). We will assess clinical effectiveness by evaluating outcomes in all women, irrespective of the HPV DNA or serology status at enrolment. Evaluation by fine age and ...
Screening for cervical cancer in Belgium" in Description of the national situation of cervical cancer screening in the member states of the European Union
European Union. There is yet high diversity in the status of cervical screening, and rapid changes expected to occur in the situation in many countries. It is important to underline differences in the health ...